Multiple myeloma had been an incurable hematological malignancy, recent advances in novel anti-neoplastic agents, including carfilzomib (CFZ), have improved the prognosis. CFZ has been reported to have cardiotoxic effects. Notably, the incidence of peripheral blood eosinophilia was not described. This is the first report of eosinophilia developing after CFZ.